Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
4 clinical trials · Condition
◉ Watch Nodal Peripheral T-Cell Lymphoma With TFH Phenotype
| Record | Firm | Date |
|---|---|---|
| Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma (NCT06561048) | Corvus Pharmaceuticals, Inc. | 2024-10-02 |
| A Registry for People With T-cell Lymphoma (NCT05978141) | Memorial Sloan Kettering Cancer Center | 2023-07-27 |
| Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma (NCT04803201) | Alliance for Clinical Trials in Oncology | 2021-10-08 |
| Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (NCT03598998) | City of Hope Medical Center | 2019-02-04 |
Track Nodal Peripheral T-Cell Lymphoma With TFH Phenotype automatically
Every clearance here is in the API, with alerts when new ones post.